478 related articles for article (PubMed ID: 25720744)
1. Liquid biopsies in patients with diffuse glioma.
Best MG; Sol N; Zijl S; Reijneveld JC; Wesseling P; Wurdinger T
Acta Neuropathol; 2015 Jun; 129(6):849-65. PubMed ID: 25720744
[TBL] [Abstract][Full Text] [Related]
2. The emerging clinical potential of circulating extracellular vesicles for non-invasive glioma diagnosis and disease monitoring.
Hallal S; Ebrahimkhani S; Shivalingam B; Graeber MB; Kaufman KL; Buckland ME
Brain Tumor Pathol; 2019 Apr; 36(2):29-39. PubMed ID: 30859343
[TBL] [Abstract][Full Text] [Related]
3. Blood-based biomarkers for the diagnosis and monitoring of gliomas.
Zachariah MA; Oliveira-Costa JP; Carter BS; Stott SL; Nahed BV
Neuro Oncol; 2018 Aug; 20(9):1155-1161. PubMed ID: 29746665
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas.
Valerius AR; Webb MJ; Hammad N; Sener U; Malani R
Curr Oncol Rep; 2024 Apr; 26(4):377-390. PubMed ID: 38488990
[TBL] [Abstract][Full Text] [Related]
5. Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy.
Panditharatna E; Kilburn LB; Aboian MS; Kambhampati M; Gordish-Dressman H; Magge SN; Gupta N; Myseros JS; Hwang EI; Kline C; Crawford JR; Warren KE; Cha S; Liang WS; Berens ME; Packer RJ; Resnick AC; Prados M; Mueller S; Nazarian J
Clin Cancer Res; 2018 Dec; 24(23):5850-5859. PubMed ID: 30322880
[TBL] [Abstract][Full Text] [Related]
6. The Role of Liquid Biopsies in Pediatric Brain Tumors.
Tang K; Gardner S; Snuderl M
J Neuropathol Exp Neurol; 2020 Sep; 79(9):934-940. PubMed ID: 32766689
[TBL] [Abstract][Full Text] [Related]
7. Circulating glioma biomarkers.
Kros JM; Mustafa DM; Dekker LJ; Sillevis Smitt PA; Luider TM; Zheng PP
Neuro Oncol; 2015 Mar; 17(3):343-60. PubMed ID: 25253418
[TBL] [Abstract][Full Text] [Related]
8. Liquid Biopsy in Primary Brain Tumors: Looking for Stardust!
Fontanilles M; Duran-Peña A; Idbaih A
Curr Neurol Neurosci Rep; 2018 Mar; 18(3):13. PubMed ID: 29520561
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid tumor DNA for liquid biopsy in glioma patients' management: Close to the clinic?
Simonelli M; Dipasquale A; Orzan F; Lorenzi E; Persico P; Navarria P; Pessina F; Nibali MC; Bello L; Santoro A; Boccaccio C
Crit Rev Oncol Hematol; 2020 Feb; 146():102879. PubMed ID: 32005411
[TBL] [Abstract][Full Text] [Related]
10. Molecular and Circulating Biomarkers of Brain Tumors.
Jelski W; Mroczko B
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34210107
[TBL] [Abstract][Full Text] [Related]
11. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
12. ExRNA in Biofluids as Biomarkers for Brain Tumors.
Rennert RC; Hochberg FH; Carter BS
Cell Mol Neurobiol; 2016 Apr; 36(3):353-60. PubMed ID: 26993514
[TBL] [Abstract][Full Text] [Related]
13. Progress on molecular biomarkers and classification of malignant gliomas.
Zhang C; Bao Z; Zhang W; Jiang T
Front Med; 2013 Jun; 7(2):150-6. PubMed ID: 23681890
[TBL] [Abstract][Full Text] [Related]
14. Time to focus on circulating nucleic acids for diagnosis and monitoring of gliomas: A systematic review of their role as biomarkers.
Díaz Méndez AB; Tremante E; Regazzo G; Brandner S; Rizzo MG
Neuropathol Appl Neurobiol; 2021 Jun; 47(4):471-487. PubMed ID: 33403678
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers define distinct types of diffuse glioma.
Cancer Discov; 2015 Aug; 5(8):787. PubMed ID: 26134050
[TBL] [Abstract][Full Text] [Related]
16. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
Shi R; Wang PY; Li XY; Chen JX; Li Y; Zhang XZ; Zhang CG; Jiang T; Li WB; Ding W; Cheng SJ
Oncotarget; 2015 Sep; 6(29):26971-81. PubMed ID: 26284486
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
[TBL] [Abstract][Full Text] [Related]
18. Ultrasensitive Immunoprofiling of Plasma Extracellular Vesicles Identifies Syndecan-1 as a Potential Tool for Minimally Invasive Diagnosis of Glioma.
Indira Chandran V; Welinder C; Månsson AS; Offer S; Freyhult E; Pernemalm M; Lund SM; Pedersen S; Lehtiö J; Marko-Varga G; Johansson MC; Englund E; Sundgren PC; Belting M
Clin Cancer Res; 2019 May; 25(10):3115-3127. PubMed ID: 30679164
[TBL] [Abstract][Full Text] [Related]
19. Glioma proteomics: status and perspectives.
Niclou SP; Fack F; Rajcevic U
J Proteomics; 2010 Sep; 73(10):1823-38. PubMed ID: 20332038
[TBL] [Abstract][Full Text] [Related]
20. Molecular diagnostics as a tool to personalize treatment in adult glioma patients.
Jeuken JW; van der Maazen RW; Wesseling P
Technol Cancer Res Treat; 2006 Jun; 5(3):215-29. PubMed ID: 16700618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
